Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

First Patient Enrolled in Novocure’s Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
First Patient Enrolled in Novocure’s Global Phase 3 TRIDENT Trial of Optune® Concurrent with Radiation Therapy in Newly Diagnosed Glioblastoma


Novocure (NASDAQ: NVCR) today announced the first patient has been enrolled in its global phase 3 TRIDENT trial, a randomized study in newly diagnosed glioblastoma (GBM) testing the potential

Acadia Healthcare Forms Joint Venture with Henry Ford Health System to Build Modern Behavioral Health Facility to Serve Detroit Area Communities: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Forms Joint Venture with Henry Ford Health System to Build Modern Behavioral Health Facility to Serve Detroit Area Communities


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Henry Ford Health System, one of Michigan’s premier, academic and integrated health systems

Charles River Delivers Industry-First Deciphex Patholytix Digital Pathology Peer Review for GLP Studies: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Delivers Industry-First Deciphex Patholytix Digital Pathology Peer Review for GLP Studies


Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is the first company to offer clients Good Laboratory Practices (GLP) validated digital peer review using Deciphex

QIAGEN Increases Outlook for 2020 and 2021
QIAGEN Increases Outlook for 2020 and 2021


QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has raised its full-year 2020 outlook for growth of net sales and adjusted earnings per share (EPS) and is looking forward

QIAGEN hebt den Ausblick für 2020 und 2021 an
QIAGEN hebt den Ausblick für 2020 und 2021 an


QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass es den Ausblick für das Wachstum des Konzernumsatzes und den bereinigten Gewinn je Aktie (EPS) für das Gesamtjahr 2020

St. Luke’s University Health Network Wins 2020 Premier Alliance Excellence Award: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
St. Luke’s University Health Network Wins 2020 Premier Alliance Excellence Award


Premier Inc. (NASDAQ: PINC) has named St. Luke’s University Health Network, a fully integrated, nationally recognized health network serving Pennsylvania and New Jersey, the winner of the 2020

AMN CEO Susan Salka Named One of Modern Healthcare’s 100 Most Influential People of 2020
AMN CEO Susan Salka Named One of Modern Healthcare’s 100 Most Influential People of 2020


Susan Salka, President and CEO of AMN Healthcare (NYSE:AMN), has been named by Modern Healthcare as one of 2020’s 100 Most Influential People. This year’s list focused on people who influenced the

LivaNova Announces Board Appointment and Board Leadership Changes: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Announces Board Appointment and Board Leadership Changes


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a series of enhancements to the Company’s governance.



Todd Schermerhorn has been appointed

Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced it has

QIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response
QIAGEN to Launch QuantiFERON SARS-CoV-2 For Research Into Causes, Spread and Control of COVID-19 Through T-cell Response


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the launch of its QuantiFERON SARS-CoV-2 RUO solution that can detect T-cell responses of the human immune system to the

QIAGEN führt QuantiFERON SARS-CoV-2 ein, Test zur Erforschung von Ursachen, Verbreitung und Kontrolle von COVID-19 durch T-Zell-Reaktion
QIAGEN führt QuantiFERON SARS-CoV-2 ein, Test zur Erforschung von Ursachen, Verbreitung und Kontrolle von COVID-19 durch T-Zell-Reaktion


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Markteinführung der QuantiFERON SARS-CoV-2 RUO-Lösung bekannt, mit der T-Zell-Reaktionen des menschlichen Immunsystems auf den

Xencor Presents Updated Data from the Phase 1 Study of Vibecotamab in Acute Myeloid Leukemia at the 2020 ASH Annual Meeting: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Presents Updated Data from the Phase 1 Study of Vibecotamab in Acute Myeloid Leukemia at the 2020 ASH Annual Meeting


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced updated data

LivaNova und Gyrus Capital schließen Vereinbarung über den Kauf des Herzklappengeschäfts: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova und Gyrus Capital schließen Vereinbarung über den Kauf des Herzklappengeschäfts


LivaNova PLC (NASDAQ:LIVN), ein marktführendes Medizintechnik- und Innovationsunternehmen, und Gyrus Capital (Gyrus), eine Investmentfirma, die sich auf Investitionen im Gesundheits- und

LivaNova to Host Satellite Symposium on Advances in Neuromodulation at American Epilepsy Society AES2020 Virtual Event: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Host Satellite Symposium on Advances in Neuromodulation at American Epilepsy Society AES2020 Virtual Event


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will host “Updates and Advances in Neuromodulation,” a satellite symposium at AES2020, the

Premier Inc. to Participate in the Guggenheim Digital Health Virtual Summit on December 8, 2020: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. to Participate in the Guggenheim Digital Health Virtual Summit on December 8, 2020


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the Guggenheim Digital

AMN Healthcare Names James Taylor as Group President and Chief Operating Officer for Physician & Leadership Solutions
AMN Healthcare Names James Taylor as Group President and Chief Operating Officer for Physician & Leadership Solutions


AMN Healthcare (NYSE: AMN) has named James Taylor as its new Group President and Chief Operating Officer for Physician & Leadership Solutions.


This press release features multimedia. View the full

LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve Business: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova and Gyrus Capital Enter into Agreement for the Purchase of Heart Valve Business


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability

AMN Healthcare Announces Initiative to Support Minority-owned Businesses
AMN Healthcare Announces Initiative to Support Minority-owned Businesses


To elevate and accelerate the growth of Minority-owned businesses, AMN Healthcare (NYSE: AMN) launched the AMN Diverse Business Pledge to help minority-owned businesses obtain Minority Business

Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality


Regulatory News:



Vifor Pharma is marking the sixth anniversary of Iron Deficiency Day, focused on raising international awareness of the serious health impact of iron deficiency and iron

LivaNova to Present at the Berenberg European Conference 2020: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Present at the Berenberg European Conference 2020


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will participate in discussions at the Berenberg European

Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference


Novocure (NASDAQ: NVCR) announced today that Novocure’s Executive Chairman William Doyle and Chief Science Officer Dr. Uri Weinberg will participate in the 3rd Annual Evercore ISI 2020 Virtual

Genus plc Provides Update on Fiscal 2021 Financial Performance
Genus plc Provides Update on Fiscal 2021 Financial Performance


Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported continued strong performance across its operations for the period from July 1, 2020 through November 24, 2020

LivaNova to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, will participate in discussions at the Piper Sandler 32nd Annual

Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Announces 43 Presentations on Tumor Treating Fields at Society for Neuro-Oncology 2020 Virtual Annual Meeting


Novocure (NASDAQ: NVCR) today announced 43 presentations on Tumor Treating Fields will be featured at the Society for Neuro-Oncology 2020 Virtual Annual Meeting on November 19 through November 21

VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement : https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
VFMCRP and Fresenius Kabi expand collaboration in nephrology in China with Veltassa® agreement


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118005914/en/



Vifor Fresenius Medical Care Renal Pharma (VFMCRP)